|
|
||||||||
1 From the Research Department, Shriners Hospitals for Children, Tampa, Florida; the 2 Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa; the 3 Division of Biology, Ackert Hall, Kansas State University, Manhattan; and the 4 University of Texas, Southwestern Medical Center, Dallas.
| Abstract |
|---|
|
|
|---|
METHODS. Keratocytes were isolated from bovine corneas using sequential collagenase digestion and cultured in Dulbeccos modified Eagles medium (DMEM), with and without fetal bovine serum (FBS). Proteoglycans synthesized by the cells in culture and by keratocytes in intact cornea culture were metabolically radiolabeled with 35SO4. The proteoglycans were characterized by their sensitivity to keratanase, chondroitinase ABC, and heparatinase and by their size on Superose 6 HR. Cell number was determined by measuring DNA content of the culture dishes.
RESULTS. Keratocytes cultured in 10% FBS proliferated, appeared fibroblastic, and synthesized only 9% of the total glycosaminoglycan as keratan sulfate (KS), whereas cells in serum-free media were quiescent, appeared dendritic, and synthesized 47% KS, a value similar to the 45% KS for corneas radiolabeled overnight in organ culture. This increased proportion of KS synthesis in serum-free media was caused by a moderate increase in KS synthesis combined with a substantial decrease in chondroitin sulfate (CS) synthesis. Fractionation on Superose 6 High Resolution showed the size and relative amounts of the CS- and KS-containing proteoglycans synthesized by keratocytes in serum-free media also more closely resembled that of keratocytes in corneas in organ culture than keratocytes in media containing serum.
CONCLUSIONS. A comparison of proteoglycan synthesis and cell morphology between keratocytes in corneas in organ culture and in cell culture indicates that keratocytes maintain a more native biosynthetic phenotype and appearance when cultured in serum-free media. These results also suggest that culturing in the presence of serum fundamentally alters the keratocyte phenotype to an activated cell, mimicking certain changes observed during wound healing.
| Introduction |
|---|
|
|
|---|
The keratocyte produces the collagens and proteoglycans that comprise
the stromal extracellular matrix. Studies using freshly isolated
monkey15
corneas have shown that proteoglycans synthesized
overnight in organ culture are similar, if not identical, in structure
and relative amounts with that present in the stromal matrix, and this
has been extended to studies in chicken16
and human
corneas11
12
17
as well. Keratan sulfate can be as much as
47% of the total glycosaminoglycan (GAG) synthesized by corneas in
organ culture.16
In contrast, keratocytes grown from
human, rabbit, and bovine corneas and cultured under standard
conditions generally produce little (~3%) or no
KS,17
18
19
although a recent study reported 15%
KS.20
Serum-cultured keratocytes also express the
fibronectin receptor
5ß1, which is not expressed by keratocytes in
situ; have a predominantly fibroblastic morphology; and show an actin
cytoskeletal organization more characteristic of corneal
myofibroblasts.21
22
23
Furthermore, when passed at low cell
density, keratocyte cultures become entirely myofibroblastic and show
changes in cadherin expression.22
24
These observations
suggest that standard cell culture conditions alter the keratocyte from
its in situ phenotype.
Standard culture conditions for keratocytes include using fetal bovine serum in the media. A recent study showed, however, that primary cultures of collagenase-isolated rabbit keratocytes cultured in serum-free media exhibited a dendritic morphology with multiple and extensive interconnective cellular processes.25 The appearance of these dendritic cells is similar to the morphology of keratocytes in situ23 26 and is distinctly different from the fibroblastic or myofibroblastic appearance of keratocytes grown in serum-containing medium. In this study we used collagenase-isolated bovine keratocytes and serum-containing or serum-free media to culture the keratocytes. The results show that collagenase-isolated bovine keratocytes cultured in serum-free media are quiescent, maintain a dendritic morphology and synthesize high levels of KSall phenotypic characteristics similar to those of in situ keratocytes or keratocytes in corneas cultured in organ culture.
| Materials and Methods |
|---|
|
|
|---|
Keratocyte and Cornea Organ Culture
Only cells obtained from the third digestion were used for cell
culture experiments. These cells were resuspended at 150,000 to 175,000
cells/ml in DMEM containing 10% FBS, DMEM containing 1% platelet-poor
horse serum (PPHS; P552; Sigma), or DMEM alone. The cell suspensions
were plated at 2 ml/35 mm dish. Cells in DMEM-10% FBS or DMEM-1% PPHS
were plated in six-well tissue culture dishes (model 3516; Costar,
Cambridge, MA), whereas cells in DMEM alone were plated in six-well
Primaria (3846; Falcon) dishes. The cells were allowed to attach
overnight and the media changed the next day (day 1). Some of the cells
plated in DMEM containing 1% PPHS were changed to DMEM on day 1. Media
were changed every 2 to 3 days. Cell cultures were radiolabeled for 2
days by the addition of media containing 50 µCi/ml
Na35SO4 (Nex-041;
DupontNew England Nuclear, Boston, MA) on day 2. Intact corneas with
a scleral rim were also incubated overnight in 2.5 ml DMEM/cornea
containing 50 µCi/ml
Na35SO4 in a 35-mm dish, as
previously described.15
Proteoglycan Isolation and Characterization
The media were removed from each culture dish at the end of the
radiolabeling period and applied directly to a Spec 3 ml NH2 column
(Ansysnic, Irvine, CA) prepared according to the manufacturers
directions. The column was washed three times with 3 ml 6 M urea
containing 0.15 M NaC1 and 0.02 M Tris (pH 7.4) to remove free
35SO4, and the bound proteoglycans were eluted
from the NH2 column with 1 ml 4 M guanidine-HCl. The proteoglycan
fraction was then dialyzed against distilled water.
Intact corneas were removed from the media at the end of the radiolabeling period and the scleral rim removed. Each cornea was extracted with 2 ml 8 M guanidine-HCl, and the extract was dialyzed against 6 M urea containing 0.15 M NaCl and 0.02M Tris (pH 7.4) and applied to a 0.4-ml column of diethylaminoethyl Sepharose (Pharmacia, Piscataway, NJ). After washing with 6 M urea, the proteoglycans were eluted with 4 M guanidine HCl and collected.
Aliquots of the proteoglycan fraction from 35SO4 radiolabeled cultures were digested with either chondroitinase ABC, keratanase, or heparatinase (Seikagaku America, Rockville, MD) for 3 hours, according to the manufacturers directions. The enzymes were inactivated by boiling, 0.5 mg carrier chondroitin sulfate (Sigma) added, and the undigested GAGs precipitated by the addition of 3 volumes of 95% ethanol containing 0.1% potassium acetate at 4°C. Insoluble (undigested) material was pelleted by centrifugation, an aliquot of the supernatant (which contained the digested GAGs) was removed, and the radioactivity was measured by liquid scintillation spectrophotometry. The percentage digested by each enzyme was calculated from the total digested by all three enzymes.
The proteoglycan fraction from the cell cultures and the intact corneas were fractionated on a column (1 x 30 cm) of Superose 6 HR in 4 M guanidine HCl. Fractions of 0.5 ml were collected, and a portion of each fraction was measured for radioactivity. Fractions were pooled and dialyzed against distilled water, and the GAG type were determined as described.
DNA Content
After removal of the media, 0.15 ml 0.1% sodium dodecyl sulfate
(SDS) was added to each culture dish for five minutes to lyse the
cells. Proteinase K (1.35 ml; 500 µg/ml 0.002 M EDTA, 0.1 M
NaP04 [pH 6.5]) was then added to each dish,
the contents of the dish scraped into the proteinase K solution. The
solution was placed in screw-capped test tubes and incubated at 60°C
overnight. The DNA content in the proteinase K digest was determined by
fluorometry, using the Hoechst 33258 dye (Hoefer Scientific; San
Francisco, CA).
| Results |
|---|
|
|
|---|
After 4 days of culture, cells in 10% FBS achieved a fibroblastic appearance (Fig. 1 , 10% FBS) whereas cells cultured continuously with 1% PPHS appeared dendritic with numerous, randomly branching, processes (Fig. 1 1 % PPHS). Cells initially plated in 1% PPHS but switched to DMEM alone on the following day appeared similar to those cultured continuously in 1% PPHS, although the central cell body appeared smaller and less spread out (Fig. 1 1 %/DMEM). By comparison, cells cultured in DMEM alone with Primaria plates were also dendritic (Fig. 1 , DMEM), but the keratocytes had relatively small cell bodies with markedly fewer cell processes. Furthermore, under these conditions, cell processes appeared to extend directly, contacting to adjacent cells without substantial branching.
|
|
|
The proteoglycans in the media of cells cultured under these different conditions and from intact corneas radiolabeled overnight in DMEM were chromatographed on a column of Superose 6 HR (Fig. 4) to evaluate proteoglycan size. The proteoglycans synthesized by cells in DMEM containing 10% FBS eluted primarily in a sharp peak early in the chromatogram (Fig. 4 , 10% FBS, area 1) with several minor peaks eluting later (area 2). The proteoglycans from the early-eluting peak (area 1) were 96% CS, whereas the proteoglycans in area 2 were 53% CS (Table 1) . A similar profile was obtained for proteoglycans from cells cultured continuously in 1% PPHS (Fig. 4 1 % PPHS), but proteoglycans in area 2 (Table 1) contained only 11% CS. Cells plated in DMEM containing 1% PPHS and switched to DMEM (Fig. 4 1 %/DMEM) and cells plated on Primaria plates in DMEM alone (Fig. 4 , DMEM) also synthesized proteoglycans that eluted in a prominent peak (area 1), early in the chromatogram, that contained almost exclusively CS (Table 1) , although it eluted three tubes later (indicating a smaller size) than the corresponding peak of cells cultured in 10% FBS. Cells in these cultures (Fig. 4 , 1%/DMEM and DMEM), however, also synthesized proteoglycans, eluting in a prominent second peak that contained almost exclusively KS (Table 1 , area 2). Radiolabeled proteoglycans from overnight cultures of intact corneas (Fig. 4 , intact cornea) also fractionated into two prominent peaks: an early- (area 1) and a late-eluting peak (area 2) that contained primarily CS and KS, respectively (Table 1) . Keratan sulfate synthesis by the cornea in organ culture was determined to be 45% of the total KS and CS combined: a value similar to that of keratocytes in DMEM alone. The results of these analyses indicate that CS-containing proteoglycans were larger than the KS-containing proteoglycans and that the profile of cells plated in 1% PPHS and switched to DMEM and the profiles of cells in DMEM alone appeared more similar to the profiles of the intact cornea than the profiles of cells cultured in 10% FBS or in 1% PPHS continuously. The results also show that CS-containing proteoglycans made by keratocytes in 10% FBS were larger than the CS-containing proteoglycans made by keratocytes cultured in serum-free media.
|
|
| Discussion |
|---|
|
|
|---|
Previous studies have evaluated proteoglycan synthesis by primary cultures of chick keratocytes isolated by collagenase, although they were cultured in media containing FBS.27 28 Chick keratocytes plated on plastic dishes in 10% FBS and then switched to 0.3% FBS synthesized as much as 17% KS,28 a value between those achieved in our studies using 10% FBS (9% KS) and 1% PPHS (29% KS). The results of our studies indicate that FBS acts primarily to stimulate CS synthesis and has only a relatively small effect on KS synthesis. It is possible that there are growth factors and cytokines in FBS that are potent stimulators of CS synthesis and that these are not present in PPHS or are present in reduced amounts. Alternatively, FBS could be inducing the fibroblastic phenotype, and this phenotype produces a large CS-containing proteoglycan as one of its characteristics. Whatever the mechanism, these results indicate that even very low levels of serum significantly stimulates CS synthesis by keratocytes.
The sequential digestion of stromal tissue used in this study may be helpful in isolating keratocytes in their native phenotype. We removed corneal epithelium using a brief (30-minute) collagenase digestion rather than by scraping, as is done in other procedures,29 which would induce keratocyte apoptosis.30 31 The second collagenase digestion yielded cells with poor viability and attachment properties. These may represent the damaged keratocytes on the cut surfaces of the stroma that would be the first to be released by collagenase digestion. The third collagenase digestion released cells with excellent viability and attachment properties. These were probably cells that were not on the cut surfaces but deeper in the stromal pieces.
Culturing keratocytes in 10% FBS also resulted in a nearly threefold
increase in the number of cells over that with DMEM alone on Primaria
plates. This difference in cell number was probably caused by
proliferation of cells in 10% FBS, whereas cells in DMEM remained
quiescent. Proliferation of keratocytes cultured in FBS has been
considered similar to the activation of keratocytes in situ after
corneal injury.23
25
In contrast to native keratocytes in
situ, serum-cultured keratocytes and in situ corneal myofibroblasts or
activated keratocytes proliferate, exhibit prominent microfilament
bundles, focal adhesions, and enhanced expression of
5ß1 integrin
and fibronectin.23
32
33
Interestingly, our current
studies also show that keratocytes cultured in 10% FBS synthesized
more than 90% CS, a value that is similar to the 95% CS synthesized
by corneal myofibroblasts in 2-week-old corneal scars.10
Furthermore, the CS-containing proteoglycans made by the myofibroblasts
in scars were larger than the CS proteoglycans made by keratocytes in
situ,10
and we found that CS proteoglycans made by
keratocytes cultured in 10% FBS were larger than the CS proteoglycans
made by keratocytes cultured in serum-free media. These findings
further support the view that culture of normal keratocytes in the
presence of serum mimics the wound-healing response, whereas the
culture of keratocytes in the absence of serum mimics the behavior of
cells in situ.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by Grants EYO8104 (JRH), EY09368 (JLF), and EYO7348 (JVJ) from the National Institutes of Health.
Submitted for publication October 27, 1998; revised February 22, 1999; accepted March 16, 1999.
Proprietary interest category: N.
| References |
|---|
|
|
|---|
-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes Cornea 15,505-516[Medline][Order article via Infotrieve]
This article has been cited by other articles:
![]() |
L. Shelton and J. A. Summers Rada Inhibition of Human Scleral Fibroblast Cell Attachment to Collagen Type I by TGFBIp Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3542 - 3552. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, S. Chen, S. Goldoni, B. W. Calder, H. C. Simpson, R. T. Owens, D. J. McQuillan, M. F. Young, R. V. Iozzo, and D. E. Birk Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan J. Biol. Chem., March 27, 2009; 284(13): 8888 - 8897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buhren, L. Nagy, J. N. Swanton, S. Kenner, S. MacRae, R. P. Phipps, and K. R. Huxlin Optical Effects of Anti-TGF{beta} Treatment after Photorefractive Keratectomy in a Cat Model Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 634 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Jester, Y. G. Lee, J. Huang, J. Houston, B. Adams, H. D. Cavanagh, and W. M. Petroll Postnatal Corneal Transparency, Keratocyte Cell Cycle Exit and Expression of ALDH1A1 Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4061 - 4069. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ebihara, S. Yamagami, L. Chen, T. Tokura, M. Iwatsu, H. Ushio, and A. Murakami Expression and Function of Toll-like Receptor-3 and -9 in Human Corneal Myofibroblasts Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3069 - 3076. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Guo, D. Kanter, M. L. Funderburgh, M. M. Mann, Y. Du, and J. L. Funderburgh A Rapid Transient Increase in Hyaluronan Synthase-2 mRNA Initiates Secretion of Hyaluronan by Corneal Keratocytes in Response to Transforming Growth Factor beta J. Biol. Chem., April 27, 2007; 282(17): 12475 - 12483. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Guerriero, J. Chen, Y. Sado, R. R. Mohan, S. E. Wilson, J. L. Funderburgh, and N. SundarRaj Loss of Alpha3(IV) Collagen Expression Associated with Corneal Keratocyte Activation Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Barbaro, E. Di Iorio, S. Ferrari, L. Bisceglia, A. Ruzza, M. De Luca, and G. Pellegrini Expression of VSX1 in Human Corneal Keratocytes during Differentiation into Myofibroblasts in Response to Wound Healing Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5243 - 5250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Musselmann, B. Kane, B. Alexandrou, and J. R. Hassell Stimulation of Collagen Synthesis by Insulin and Proteoglycan Accumulation by Ascorbate in Bovine Keratocytes In Vitro Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5260 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yamamoto, N. Yamamoto, M. W. Petroll, J. V. Jester, and H. D. Cavanagh Regulation of Pseudomonas aeruginosa Internalization after Contact Lens Wear In Vivo and in Serum-Free Culture by Ocular Surface Cells. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3430 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chwa, S. R. Atilano, V. Reddy, N. Jordan, D. W. Kim, and M. C. Kenney Increased Stress-Induced Generation of Reactive Oxygen Species and Apoptosis in Human Keratoconus Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1902 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawakita, E. M. Espana, H. He, R. Smiddy, J.-M. Parel, C.-Y. Liu, and S. C. G. Tseng Preservation and Expansion of the Primate Keratocyte Phenotype by Downregulating TGF-{beta} Signaling in a Low-Calcium, Serum-Free Medium Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1918 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahearne, Y. Yang, A. J El Haj, K. Y Then, and K.-K. Liu Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications J R Soc Interface, December 22, 2005; 2(5): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Musselmann, B. Alexandrou, B. Kane, and J. R. Hassell Maintenance of the Keratocyte Phenotype during Cell Proliferation Stimulated by Insulin J. Biol. Chem., September 23, 2005; 280(38): 32634 - 32639. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawakita, E. M. Espana, H. He, A. Hornia, L.-K. Yeh, J. Ouyang, C.-Y. Liu, and S. C. G. Tseng Keratocan Expression of Murine Keratocytes Is Maintained on Amniotic Membrane by Down-regulating Transforming Growth Factor-{beta} Signaling J. Biol. Chem., July 22, 2005; 280(29): 27085 - 27092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Jester, A. Budge, S. Fisher, and J. Huang Corneal Keratocytes: Phenotypic and Species Differences in Abundant Protein Expression and In Vitro Light-Scattering Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2369 - 2378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Poon, A. H. Plaas, D. R. Keene, D. J. McQuillan, K. Last, and A. J. Fosang N-Linked Keratan Sulfate in the Aggrecan Interglobular Domain Potentiates Aggrecanase Activity J. Biol. Chem., June 24, 2005; 280(25): 23615 - 23621. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yoshida, S. Shimmura, J. Shimazaki, N. Shinozaki, and K. Tsubota Serum-Free Spheroid Culture of Mouse Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Hao, K. Suzuki, Y. Lu, S. Hirano, K. Fukuda, N. Kumagai, K. Kimura, and T. Nishida Inhibition of Gap Junction-Mediated Intercellular Communication by TNF-{alpha} in Cultured Human Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1195 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stramer and M. E. Fini Uncoupling Keratocyte Loss of Corneal Crystallin from Markers of Fibrotic Repair Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4010 - 4015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chakravarti, F. Wu, N. Vij, L. Roberts, and S. Joyce Microarray Studies Reveal Macrophage-like Function of Stromal Keratocytes in the Cornea Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3475 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Espana, T. Kawakita, C.-Y. Liu, and S. C. G. Tseng CD-34 Expression by Cultured Human Keratocytes Is Downregulated during Myofibroblast Differentiation Induced by TGF-{beta}1 Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2985 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brown, B. Lin, and B. Holguin Expression of Neuregulin 1, a Member of the Epidermal Growth Factor Family, Is Expressed as Multiple Splice Variants in the Adult Human Cornea Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3021 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stramer, M. G. K. Kwok, P. J. Farthing-Nayak, J.-C. Jung, M. E. Fini, and R. C. Nayak Monoclonal Antibody (3G5)-Defined Ganglioside: Cell Surface Marker of Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Espana, H. He, T. Kawakita, M. A. Di Pascuale, V. K. Raju, C.-Y. Liu, and S. C. G. Tseng Human Keratocytes Cultured on Amniotic Membrane Stroma Preserve Morphology and Express Keratocan Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5136 - 5141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Funderburgh, M. M. Mann, and M. L. Funderburgh Keratocyte Phenotype Mediates Proteoglycan Structure: A ROLE FOR FIBROBLASTS IN CORNEAL FIBROSIS J. Biol. Chem., November 14, 2003; 278(46): 45629 - 45637. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Ryan, L. Taliana, L. Sun, Z.-G. Wei, S. K. Masur, and R. M. Lavker Involvement of S100A4 in Stromal Fibroblasts of the Regenerating Cornea Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4255 - 4262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Jester, J. Huang, S. Fisher, J. Spiekerman, J. H. Chang, W. E. Wright, and J. W. Shay Myofibroblast Differentiation of Normal Human Keratocytes and hTERT, Extended-Life Human Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1850 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Maertzdorf, A. D. M. E. Osterhaus, and G. M. G. M. Verjans IL-17 Expression in Human Herpetic Stromal Keratitis: Modulatory Effects on Chemokine Production by Corneal Fibroblasts J. Immunol., November 15, 2002; 169(10): 5897 - 5903. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Berryhill, R. Kader, B. Kane, D. E. Birk, J. Feng, and J. R. Hassell Partial Restoration of the Keratocyte Phenotype to Bovine Keratocytes Made Fibroblastic by Serum Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3416 - 3421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. D. Carbone, and M. A. Watsky Receptor-Mediated Activation of a Cl- Current by LPA and S1P in Cultured Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3202 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q H Song, V E Klepeis, M A Nugent, and V Trinkaus-Randall TGF-{beta}1 regulates TGF-{beta}1 and FGF-2 mRNA expression during fibroblast wound healing Mol. Pathol., June 1, 2002; 55(3): 164 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chandrasekher, X. Ma, T. E. Lallier, and H. E. P. Bazan Delay of Corneal Epithelial Wound Healing and Induction of Keratocyte Apoptosis by Platelet-Activating Factor Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1422 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Funderburgh, M. L. Funderburgh, M. M. Mann, L. Corpuz, and M. R. Roth Proteoglycan Expression during Transforming Growth Factor beta -induced Keratocyte-Myofibroblast Transdifferentiation J. Biol. Chem., November 16, 2001; 276(47): 44173 - 44178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Hong, J. J. Liu, J.-S. Lee, R. R. Mohan, R. R. Mohan, D. J. Woods, Y.-G. He, and S. E. Wilson Proinflammatory Chemokine Induction in Keratocytes and Inflammatory Cell Infiltration into the Cornea Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2795 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Maltseva, P. Folger, D. Zekaria, S. Petridou, and S. K. Masur Fibroblast Growth Factor Reversal of the Corneal Myofibroblast Phenotype Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2490 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stramer, J. R. Cook, M. E. Fini, A. Taylor, and M. Obin Induction of the Ubiquitin-Proteasome Pathway during the Keratocyte Transition to the Repair Fibroblast Phenotype Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1698 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Berryhill, M. P. Beales, and J. R. Hassell Production of Prostaglandin D Synthase as a Keratan Sulfate Proteoglycan by Cultured Bovine Keratocytes Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1201 - 1207. [Abstract] [Full Text] |
||||
![]() |
J. K. Maurer, A. Molai, R. D. Parker, Li Li, G. J. Carr, W. M. Petroll, H. D. Cavanagh, and J. V. Jester Pathology of Ocular Irritation with Bleaching Agents in the Rabbit Low-Volume Eye Test Toxicol Pathol, April 1, 2001; 29(3): 308 - 319. [Abstract] [PDF] |
||||
![]() |
X. Ma and H. E. P. Bazan Increased Platelet-Activating Factor Receptor Gene Expression by Corneal Epithelial Wound Healing Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1696 - 1702. [Abstract] [Full Text] |
||||
![]() |
C. J. Long, M. R. Roth, E. S. Tasheva, M. Funderburgh, R. Smit, G. W. Conrad, and J. L. Funderburgh Fibroblast Growth Factor-2 Promotes Keratan Sulfate Proteoglycan Expression by Keratocytes in Vitro J. Biol. Chem., April 28, 2000; 275(18): 13918 - 13923. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |